Brief: Sprint Bioscience Q2 operating result swings to profit SEK 4.1 mln
Aug 24 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 revenue 17.8 million Swedish crowns ($2.12 million) versus 1.1 million crowns year ago
* Q2 oper profit 4.1 million crowns versus loss 5.0 million crowns year ago
Source text for Eikon: ID:nWkrhw4980
Further company coverage: SPRINT.ST
($1 = 8.3885 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program